A congenic strain of rat for investigation of control of estrogen-induced growth.
A congenic strain of rat for investigation of control of estrogen-induced growth.
复制标题
用于研究雌激素诱导生长控制的大鼠同源品系。
DOI:
10.1007/s00335-002-2183-6
复制
发表时间:
2002
期刊:
影响因子:
--
通讯作者:
Kelley,Parker
中科院分区:
文献类型:
--
作者:
Wendell,DouglasL;Pandey,Jyotsna;Kelley,Parker
The rat pituitary has been used for several decades as a model system to investigate the role of estrogen in tumor growth, cell proliferation, and angiogenesis. A major reason for using the rat pituitary is the great difference between laboratory rat strains in the effect of chronic estrogen treatment on pituitary tumor growth (Wiklund and Gorski 1982; Wendell et al. 1996; Spady et al. 1999). For example, when rats of the inbred strain Fischer 344 (F344) are given a chronic estrogen treatment, the pituitary grows continuously to become over 10 times normal mass in 8 weeks (Wiklund and Gorski 1982). Whereas the F344 strain is deficient in growth control, the Brown Norway (BN) rat strain is proficient in the control of estrogen-stimulated pituitary growth and does not form a pituitary tumor, nor even any significant change in pituitary mass, upon chronic estrogen treatment (Wendell et al. 1996). This estrogen-induced pituitary tumor (so-called due to its excessive growth) exhibits uncontrolled cell proliferation and consists primarily of lactotrophs (Phelps and Hymer 1983). When rats are administered estrogen for several days, cells in the pituitary of tumor-resistant Holtzman rats are first stimulated to proliferate, but then become refractory to the hormone (Wiklund and Gorski 1982). This refractory response is not due to insensitivity to hormone, because the pituitary continues to synthesize and release prolactin (Wiklund et al. 1981). Thus, there must be an active negative feedback mechanism specific to growth. Uncovering the basis of the difference between tumor-susceptible and tumor-resistant strains can shed light on the means by which normal cells subsequently restrain growth. The difference in growth control between F344 and BN is polygenic and owing to at least six quantitative trait loci (QTL) that were mapped in two-generation genetic crosses between BN and F344 (Wendell and Gorski 1997). Edpm3 (estrogendependent pituitary mass QTL on rat Chr3) was the QTL with largest effect (16.6% of total phenotypic variance) identified in an F2 intercross between F344 and BN (Wendell and Gorski 1997) and has been selected for further study. The BN allele of Edpm3 correlates with control of pituitary growth in estrogentreated rats, and inheritance of the F344 allele of Edpm3 correlates with uncontrolled estrogen-dependent growth (Wendell and Gorski 1997).To investigate the contribution of Edpm3 to the control of estrogen-dependent growth, we constructed a congenic strain in which the segment of rat Chr3 containing the Edpm3 QTL from BN was introgressed into the F344 strain. Thus, this strain is homozygous for the BN allele of Edpm3, but homozygous for the F344 alleles of all other QTL. The congenic strain was bred by what is now the standard ‘‘speed congenic’’